DIABETES MONITORING AND CONTROL TECHNOLOGY

VolverGo back

Resultados 145 results. LastUpdate Updated on 18/06/2021 [18:00:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Page1/6 nextPage   results/page


TRANSLATING THERAPY PARAMETERS OF AN INSULIN THERAPY SYSTEM TO TRANSLATED THERAPY PARAMETERS FOR USE AT A DIFFERENT INSULIN THERAPY SYSTEM

Publication No.: US2021178067A1 17/06/2021

Applicant:

MEDTRONIC MINIMED INC [US]

Absstract of: US2021178067A1

Systems, storage media and computer-readable media are provided for translating one or more therapy parameters of a first insulin therapy system to one or more translated therapy parameters for use at a second insulin therapy system that is different than the first insulin therapy system. A therapy profile generated at the first insulin therapy system can be send to a translation service. The therapy profile includes one or more therapy parameters. At least one therapy parameter from the therapy profile can be translated into at least one translated therapy parameter that is mapped to and adapted for use by the second insulin therapy system. The at least one translated therapy parameter can then be sent to the second insulin therapy system for use at the second insulin therapy system.

traducir

MODULAR IMPLANTABLE MEDICAL DEVICE

Publication No.: US2021177314A1 17/06/2021

Applicant:

ROCHE DIABETES CARE INC [US]

CN_112584894_A

Absstract of: US2021177314A1

An implantable medical device has an implantable power supply and an implantable medical unit. The implantable supply powers the device and it includes a hermetically sealed supply housing, a battery, and a supply power coupler that powers the implantable medical unit from the battery via a wireless coupling. The implantable medical device also has a hermetically sealed medical unit housing, and it includes a functional medical module including a continuous glucose meter module. In use, the implantable medical unit is releasably mechanically coupled to the implantable supply and a wireless coupling of a medical unit power coupler with a supply power coupler is made, thereby powering the medical unit from the battery of the implantable supply.

traducir

ADJUSTING OPERATION OF A MEDICATION DELIVERY SYSTEM IN RESPONSE TO GESTURE-INDICATED ACTIVITY CHANGES

Publication No.: US2021178068A1 17/06/2021

Applicant:

MEDTRONIC MINIMED INC [US]

Absstract of: US2021178068A1

A system disclosed here includes an insulin infusion device, a gesture-based physical behavior detection system that generates gesture data for a user, and a controller that controls operation of the insulin infusion device. The controller performs adaptive training of at least one feature, function, setting, or model associated with the insulin infusion device, based at least in part on the sensor data. The controller processes activity-identifying data that indicates a current behavior pattern of the user, and that includes gesture data provided by the gesture-based physical behavior detection system. The controller determines, from the activity-identifying data, that the current behavior pattern differs from a currently implemented therapy behavior pattern of the user, and, in response to the determination, alters the adaptive training of the at least one feature, function, setting, or model.

traducir

TECHNIQUES AND DEVICES PROVIDING ADAPTIVITY AND PERSONALIZATION IN DIABETES TREATMENT

Publication No.: WO2021113647A1 10/06/2021

Applicant:

INSULET CORP [US]

US_2021170104_A1

Absstract of: WO2021113647A1

Disclosed are a device, system, methods and computer-readable medium products that provide an updated insulin-to-carbohydrate ratio and an updated total daily insulin. The described processes may be used for periodic updating of the insulin-to-carbohydrate ratio and the total daily insulin. The insulin-to-carbohydrate ratio and/or the total may be used in the calculation of new doses of insulin that a drug delivery device may be commanded to deliver to a user.

traducir

ARRANGEMENT FOR OPERATING A BIOSENSOR AND ARRANGEMENT FOR DETERMINING THE GLUCOSE CONTENT IN THE BLOOD

Publication No.: WO2021110977A1 10/06/2021

Applicant:

CIS FORSCHUNGSINSTITUT FUER MIKROSENSORIK GMBH [DE]
EYESENSE GMBH [DE]

DE_102019133365_A1

Absstract of: WO2021110977A1

The invention relates to an arrangement for operating a biosensor (01) which emits radiation. The arrangement comprises an excitation light source (03) which generates at least one quantity of excitation radiation for the biosensor; a coupling fibre (04) at the incident surface of which the excitation radiation is injected; an optical Y coupler (12) having an excitation arm (11) which is connected to the exit surface of the coupling fibre (04), a detector arm (13) which is connected to an optical detector (21), and a sensor foot (14) which can be connected to the biosensor (01). The excitation arm (11) has a conical shape. The beam axis of the excitation arm (11) forms an angle ranging from 5° to 70° with the main beam axis of the detector arm (13). The diameter of the excitation arm (11) is, at the point of connection (16) with the detector arm, less than two thirds of the diameter of the detector arm (13). The invention also relates to an arrangement for determining the glucose content, more particularly in the blood.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

Publication No.: US2021169380A1 10/06/2021

Applicant:

DEXCOM INC [US]

US_2019015020_PA

Absstract of: US2021169380A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

TECHNIQUES AND DEVICES PROVIDING ADAPTIVITY AND PERSONALIZATION IN DIABETES TREATMENT

Publication No.: US2021170104A1 10/06/2021

Applicant:

INSULET CORP [US]

Absstract of: US2021170104A1

Disclosed are a device, system, methods and computer-readable medium products that provide an updated insulin-to-carbohydrate ratio and an updated total daily insulin. The described processes may be used for periodic updating of the insulin-to-carbohydrate ratio and the total daily insulin. The insulin-to-carbohydrate ratio and/or the total may be used in the calculation of new doses of insulin that a drug delivery device may be commanded to deliver to a user.

traducir

IMPEDIMETRIC/CAPACITIVE REUSABLE BLOOD GLUCOSE MEASUREMENT WITH MOLECULAR IMPRINTED POLYMERS

Publication No.: WO2021112802A1 10/06/2021

Applicant:

EGE UNIV [TR]

Absstract of: WO2021112802A1

The present invention relates to a sensor that can be used to measure blood glucose using molecular imprinting technology. The present invention generally relates to fast and precise, single frequency based impedimetric/capacitive electrochemical sensors in order to determine the amount of sugar (glucose, analyte) in liquid samples.

traducir

BLOOD GLUCOSE MEASUREMENT DEVICE

Publication No.: US2021169383A1 10/06/2021

Applicant:

SAMSUNG ELECTRONICS CO LTD [KR]

KR_20190084452_A

Absstract of: US2021169383A1

A blood glucose measurement device is disclosed. The present blood glucose measurement device comprises: a substrate; a first resonance sensor and a second resonance sensor arranged on the substrate; and a shield layer arranged below the second resonance sensor with respect to the direction from the second resonance sensor toward a subject.

traducir

SYSTEMS OF CENTRALIZED DATA EXCHANGE FOR MONITORING AND CONTROL OF BLOOD GLUCOSE

Publication No.: US2021169409A1 10/06/2021

Applicant:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2016331310_A1

Absstract of: US2021169409A1

A flexible system capable of utilizing data from different monitoring techniques and capable of providing assistance to patients with diabetes at several scalable levels, ranging from advice about long-term trends and prognosis to real-time automated closed-loop control (artificial pancreas). These scalable monitoring and treatment strategies are delivered by a unified system called the Diabetes Assistant (DiAs) platform. The system provides a foundation for implementation of various monitoring, advisory, and automated diabetes treatment algorithms or methods. The DiAs recommendations are tailored to the specifics of an individual patient, and to the patient risk assessment at any given moment. A central data exchange node or server collects patient data from individual DiAs devices and provides safety assurance, monitoring, telemedicine and database building for the DiAs system.

traducir

ACTIVITY TRACKING AND CLASSIFICATION FOR DIABETES MANAGEMENT SYSTEM, APPARATUS, AND METHOD

Publication No.: US2021174971A1 10/06/2021

Applicant:

UNIV CALIFORNIA [US]

WO_2020005822_PA

Absstract of: US2021174971A1

Activity tracking and classification for diabetes management is disclosed. In an example, an application operating on a user device or a server is configured to collect and synchronize lifelog data of a patient to atomic time intervals based on a time the lifelog data occurred or was recorded. The application or server is configured to segment the atomic intervals into daily activity intervals of first-level activities by determining if consecutive atomic intervals have a similar pattern of physical activity using at least a portion of the lifelog data. The application or server next selects a common daily activity model that corresponds to the patient and performs second-level activity recognition for each of the daily activity intervals using the selected common daily activity model. The application or server then generates, for display a personal chronical of the recognized second-level activities.

traducir

Systems and methods for patient monitoring using an HCP-specific device

Publication No.: AU2021203005A1 10/06/2021

Applicant:

DEXCOM INC [US]

US_2021142912_A1

Absstract of: AU2021203005A1

Systems and methods disclosed provide ways for Health Care Professionals (HCPs) to be involved in initial patient system set up so that the data received is truly transformative, such that the patient not just understands what all the various numbers mean but also how the data can be used. For example, in one implementation, a CGM device is configured for use by a HCP, and includes a housing and a circuit configured to receive a signal from a transmitter coupled to an indwelling glucose sensor. A calibration module converts the received signal into clinical units. A user interface is provided that is configured to display a measured glucose concentration in the clinical units. The user interface is further configured to receive input data about a patient level, where the input data about the patient level causes the device to operate in a mode appropriate to the patient level. WO 2018/125841 PCT/US2017/068327 LU>-U ~> I2 U -)

traducir

AN AIR BUBBLE DETECTION SYSTEM AND A DETECTION METHOD FOR INSULIN INFUSION SETS

Publication No.: WO2021112804A1 10/06/2021

Applicant:

CANKAYA NIHAT [TR]

Absstract of: WO2021112804A1

The invention relates to an air bubble detection device that detects air bubbles present in insulin passing through infusion sets used in the treatment of diabetes mellitus. It comprises a film sensor, an electronic circuit, a smartphone, and interface software that works on this smartphone and provides the coordination of all the equipment. The device can be adhered to the infusion sets of all types and sizes.

traducir

PSYCHOTHERAPY DEVICE FOR SENSING BRAIN WAVE SIGNAL, PSYCHOTHERAPY SYSTEM FOR DISPLAYING AND STORING BRAIN WAVE SIGNAL BY USING SAME, AND SYSTEM FOR MANAGING BRAIN WAVE SIGNAL THROUGH INTERMEDIATE MANAGER

Publication No.: WO2021112270A1 10/06/2021

Applicant:

HUMANLINE CO LTD [KR]

Absstract of: WO2021112270A1

The present invention relates to a psychotherapy device capable of measuring brain waves, comprising a body, a band, and a cushioning material. The body includes: a LED bar; a protection film; a brain wave measuring sensing means including one grounding electrode and a pair of brain wave measuring electrodes installed on both eye regions of the inner side of the body having the LED bar installed thereon so as to measure brain waves which are a type of bio-signal; and an USB interface for coupling same to a personal computer or smartphone. The psychotherapy device is connected to a personal computer or smartphone so as to operate, by using the personal computer or smartphone, according to a signal requesting measurement of the user's brain waves. The psychotherapy device transmits the sensed brain wave signal to the personal computer or smartphone, and performs electrocardiogram through an electrocardiogram sensor mounted on the user's ear. The psychotherapy device senses brain waves through the brain wave measuring sensing means, performs a brain stimulation operation, and transmits a brain wave signal to the personal computer or smartphone so that changes in the brain waves before/after use of the psychotherapy device are displayed in a three-dimensional waveform. The brain wave measuring sensing means provides a brain wave measurement signal, an oxygen saturation signal, a pulse rate, and a heart rate signal, which are related to the user, to the personal computer or smartp

traducir

CONTINUOUS BLOOD SUGAR MEASURING DEVICE

Publication No.: EP3831298A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019315233_A1

Absstract of: EP3831298A1

The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

traducir

BODY ATTACHMENT UNIT FOR CONTINUOUS BLOOD GLUCOSE MONITORING

Publication No.: EP3831297A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019313138_A1

Absstract of: EP3831297A1

The present invention relates to a body attachment unit for continuous blood glucose monitoring, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and activation can occur in a stabilized state, and thereby allowing more accurate blood glucose monitoring.

traducir

CONTINUOUS GLUCOSE MONITORING DEVICE

Publication No.: EP3831295A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019314012_A1

Absstract of: EP3831295A1

The present disclosure relates to a continuous glucose monitoring device, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work for a user in attaching the body attachment unit to a body, and allowing attachment of the body attachment unit to the body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, the continuous glucose monitoring device is activated by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and the continuous glucose monitoring device can be activated in a stabilized state, and thereby can monitor blood glucose more accurately.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT BODY ATTACHMENT UNIT

Publication No.: EP3831296A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019316452_A1

Absstract of: EP3831296A1

The present disclosure relates to a continuous blood glucose measurement body attachment unit, and provides a continuous blood glucose measurement body attachment unit, which is manufactured in an assembled state in an applicator so as to minimize separate additional operations, such that the body attachment unit can be attached to the body with only a simple operation of the applicator and, particularly, the body attachment unit has a wireless communication chip so as to be capable of communicating with an external terminal, thereby enabling simple and convenient usage without an additional operation in which a separate transmitter must be connected and enabling maintenance to be more easily performed, and after the body attachment unit is attached to the body, an operation starts by the control of a user, such that an operation start time point can be adjusted to an appropriate time point according to the needs of the user, and an operation can start in a stabilized state, such that blood glucose can be more accurately measured.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT APPARATUS

Publication No.: EP3831299A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019313136_A1

Absstract of: EP3831299A1

The present invention relates to a continuous blood glucose measurement apparatus which, by manufacturing a body-attachable unit in an assembled state inside an applicator, minimizes the additional work by a user for attaching the body-attachable unit to the body and thus enables the body-attachable unit to be attached to the body simply by means of operating the applicator, and, by providing a wireless communication chip on the body-attachable unit and enabling communication with an external terminal, can be used in a simple and convenient manner without the additional work of connecting a separate transmitter and enables easier maintenance and management, and, by having the operation of the body-attachable unit initiated by means of the user's manipulation after being attached to the body, enables the operation initiation point to be adjusted to an appropriate point as necessary by the user, enables an operation initiation in a stabilized state and thus enables more accurate blood glucose measurement.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT BODY ATTACHMENT UNIT

Publication No.: EP3831293A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019313135_A1

Absstract of: EP3831293A1

The present disclosure relates to a continuous blood glucose measurement body attachment unit, and provides a continuous blood glucose measurement body attachment unit, which is manufactured in an assembled state in an applicator so as to minimize separate additional operations, such that the body attachment unit can be attached to the body with only a simple operation of the applicator and, particularly, the body attachment unit has a wireless communication chip so as to be capable of communicating with an external terminal, thereby enabling simple and convenient usage without an additional operation in which a separate transmitter must be connected and enabling maintenance to be more easily performed, and after the body attachment unit is attached to the body, an operation starts by the control of a user, such that an operation start time point can be adjusted to an appropriate time point according to the needs of the user, and an operation can start in a stabilized state, such that blood glucose can be more accurately measured.

traducir

BODY ATTACHMENT UNIT FOR CONTINUOUS GLUCOSE MONITORING

Publication No.: EP3831302A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019316453_A1

Absstract of: EP3831302A1

The present invention relates to a body attachment unit for continuous glucose monitoring. The present invention provides a body attachment unit for continuous glucose monitoring, wherein: the body attachment unit is manufactured in the state in which the body attachment unit is assembled in an applicator, and thus separate additional work is minimized and the body attachment unit can be attached to the body by simply operating the applicator; in particular, a wireless communication chip is disposed in the body attachment unit so as to communicate with an external terminal, and thus simple and convenient use can be achieved without any additional work for connection of a separate transmitter and maintenance and management can also be easily performed; and the monitoring operation is started by a user's manipulation after the body attachment unit is attached to the body, and thus the user can adjust the operation start time to an appropriate point as necessary and the operation can be started in a stabilized state so as to enable more accurate glucose monitoring.

traducir

BODY ATTACHMENT UNIT FOR CONTINUOUS BLOOD GLUCOSE MONITORING

Publication No.: EP3831301A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019314013_A1

Absstract of: EP3831301A1

The present invention relates to a body attachment unit for continuous blood glucose monitoring, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and activation occurs in a stabilized state, thereby allowing more accurate blood glucose monitoring.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT DEVICE

Publication No.: EP3831300A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019316455_A1

Absstract of: EP3831300A1

The present invention relates to a continuous blood glucose measurement device which is produced with an assembled body attachment unit inside an applicator so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body by simply activating the applicator, and, particularly, the present invention provides a continuous blood glucose measurement device which: is provided with a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use, without additional work of connecting a separate transmitter, and easier maintenance; and is activated by the user after the body attachment unit is attached to the body so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.

traducir

CONTINUOUS GLUCOSE MONITORING DEVICE

Publication No.: EP3831294A1 09/06/2021

Applicant:

I SENS INC [KR]

AU_2019314020_A1

Absstract of: EP3831294A1

The present disclosure relates to a continuous glucose monitoring device. The present disclosure provides a continuous glucose monitoring device wherein: a body attachment unit is manufactured in the state in which the body attachment unit is assembled in an applicator, and thus a user's additional work for attaching the body attachment unit to the body is minimized and the body attachment unit can be attached to the body by simply operating the applicator; in particular, a wireless communication chip is disposed in the body attachment unit so as to communicate with an external terminal, and thus simple and convenient use can be achieved without any additional work for connection of a separate transmitter and maintenance and management can also be easily performed; and the monitoring operation is started by the user's manipulation after the body attachment unit is attached to the body, and thus the user can adjust the operation start time to an appropriate point as necessary and the operation can be started in a stabilized state so as to enable more accurate glucose monitoring.

traducir

ANALYTE SENSOR

Nº publicación: US2021161434A1 03/06/2021

Applicant:

DEXCOM INC [US]

US_11020031_B1

Absstract of: US2021161434A1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

traducir

Page1/6 nextPage results/page

punteroimgGo back